FibroBiologics, Inc. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported net loss was USD 8.46 million compared to USD 2.42 million a year ago. Basic loss per share from continuing operations was USD 0.27 compared to USD 0.18 a year ago.

Diluted loss per share from continuing operations was USD 0.27 compared to USD 0.18 a year ago.